Cleared Traditional

K160561 - Boosting Catheter

K160561 is an FDA 510(k) clearance for Boosting Catheter, manufactured by Qxmedical, LLC. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 247-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2016
Decision
247d
Days
Class 2
Risk

K160561 is an FDA 510(k) clearance for the Boosting Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Qxmedical, LLC (Saint Paul, US). The FDA issued a Cleared decision on November 2, 2016 after a review of 247 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Qxmedical, LLC devices

FDA 510(k) Submission Details - K160561

510(k) Number K160561 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 29, 2016
Decision Date November 02, 2016
Days to Decision 247 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
122d slower than avg
Panel avg: 125d · This submission: 247d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 780
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K160561.
Trapper Exchange Device
K162253 · Creganna Medical Aslo Business AS Cregganna Tactx Medical · Jan 2017
YOGA Microcatheter
K162563 · Codman & Shurtleff, Inc. · Jan 2017
AMPLATZER TorqVue 45x45 Delivery Sheath
K163000 · Aga Medical COrporation (Wholly Owned by St. Jude Medical CO · Dec 2016
R2P SlenGuide
K161546 · Ashitaka Factory of Terumo Corporation · Oct 2016
Navien Intracranial Support Catheter
K161152 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Oct 2016
TrailBlazer Angled Support Catheter
K162384 · Medtronic Vascular, Inc.(Formerly Ev3 Inc.) · Sep 2016